• 文献检索
  • 文档翻译
  • 深度研究
  • 学术资讯
  • Suppr Zotero 插件Zotero 插件
  • 邀请有礼
  • 套餐&价格
  • 历史记录
应用&插件
Suppr Zotero 插件Zotero 插件浏览器插件Mac 客户端Windows 客户端微信小程序
定价
高级版会员购买积分包购买API积分包
服务
文献检索文档翻译深度研究API 文档MCP 服务
关于我们
关于 Suppr公司介绍联系我们用户协议隐私条款
关注我们

Suppr 超能文献

核心技术专利:CN118964589B侵权必究
粤ICP备2023148730 号-1Suppr @ 2026

文献检索

告别复杂PubMed语法,用中文像聊天一样搜索,搜遍4000万医学文献。AI智能推荐,让科研检索更轻松。

立即免费搜索

文件翻译

保留排版,准确专业,支持PDF/Word/PPT等文件格式,支持 12+语言互译。

免费翻译文档

深度研究

AI帮你快速写综述,25分钟生成高质量综述,智能提取关键信息,辅助科研写作。

立即免费体验

叙利亚患者子宫平滑肌瘤中外显子2-MED12突变的检测

Detection of exon2-MED12 mutations in uterine leiomyomas from Syrian patients.

作者信息

Albitar Lina, Al-Chatty Eyad, Ahmad Fariz

机构信息

Department of Pathology, Faculty of Medicine, Damascus University, Damascus, Syria.

Department of Pathology, National University Hospital, Damascus, Syria.

出版信息

Sci Rep. 2025 Jan 2;15(1):452. doi: 10.1038/s41598-024-84439-4.

DOI:10.1038/s41598-024-84439-4
PMID:39747270
原文链接:https://pmc.ncbi.nlm.nih.gov/articles/PMC11697450/
Abstract

Uterine leiomyomas (uLMs) are the most prevalent benign tumors of the female reproductive system. MED12 is one of the mediator complex subunits that has been implicated in uLMs pathogenesis. Somatic mutations in exon2-MED12 have been found in ~ 70% of uLMs. In this study, we investigated the status of exon2-MED12 in uLMs from Syrian patients. Sixteen leiomyomas from nine patients were assessed. Genomic DNA was isolated from tumors and exon2-MED12 was amplified by PCR and sequenced. Three specimens showed in frame point mutations consisted of missense substitutions in codon 44 (c.130). A novel insertion in codon 35 (c.103insG) was detected in one of the mutated cases and is expected to cause a frameshift in translation and an altered or truncated product. Some of the wild-type uLMs were collected from the same uteri that revealed mutations, which emphasizes the individuality of the uLM lesions and highlights the complexity of uLMs pathogenesis. The study is the first report from Syria on the topic and the second from the Arab world. It indicates genetic heterogeneity and independent clonal origin of the somatic mutations in exon2-MED12. In wild-type uLMs where exon2-MED12 mutations are absent, other players are in place and should be investigated.

摘要

子宫平滑肌瘤(uLMs)是女性生殖系统中最常见的良性肿瘤。MED12是中介体复合物亚基之一,与uLMs的发病机制有关。在约70%的uLMs中发现了外显子2-MED12的体细胞突变。在本研究中,我们调查了叙利亚患者uLMs中外显子2-MED12的状态。对9名患者的16个平滑肌瘤进行了评估。从肿瘤中分离基因组DNA,通过PCR扩增外显子2-MED12并进行测序。三个标本显示框内点突变,由密码子44(c.130)的错义替换组成。在其中一个突变病例中检测到密码子35的一个新插入(c.103insG),预计会导致翻译移码并产生改变或截短的产物。一些野生型uLMs是从发现有突变的同一子宫中收集的,这强调了uLM病变的个体性,并突出了uLMs发病机制的复杂性。该研究是叙利亚关于该主题的首次报告,也是阿拉伯世界的第二篇报告。它表明外显子2-MED12体细胞突变的遗传异质性和独立克隆起源。在不存在外显子2-MED12突变的野生型uLMs中,其他因素起作用,应进行研究。

https://cdn.ncbi.nlm.nih.gov/pmc/blobs/6654/11697450/081705f4edda/41598_2024_84439_Fig3_HTML.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/6654/11697450/953424cfca5c/41598_2024_84439_Fig1_HTML.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/6654/11697450/aac90617bf58/41598_2024_84439_Fig2_HTML.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/6654/11697450/081705f4edda/41598_2024_84439_Fig3_HTML.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/6654/11697450/953424cfca5c/41598_2024_84439_Fig1_HTML.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/6654/11697450/aac90617bf58/41598_2024_84439_Fig2_HTML.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/6654/11697450/081705f4edda/41598_2024_84439_Fig3_HTML.jpg

相似文献

1
Detection of exon2-MED12 mutations in uterine leiomyomas from Syrian patients.叙利亚患者子宫平滑肌瘤中外显子2-MED12突变的检测
Sci Rep. 2025 Jan 2;15(1):452. doi: 10.1038/s41598-024-84439-4.
2
Mutational analysis of MED12 exon 2 in uterine leiomyoma and other common tumors.子宫平滑肌瘤和其他常见肿瘤 MED12 外显子 2 的突变分析。
Int J Cancer. 2012 Sep 15;131(6):E1044-7. doi: 10.1002/ijc.27610. Epub 2012 May 8.
3
Highly heterogeneous genomic landscape of uterine leiomyomas by whole exome sequencing and genome-wide arrays.通过全外显子组测序和全基因组芯片分析子宫平滑肌瘤高度异质性的基因组格局
Fertil Steril. 2017 Feb;107(2):457-466.e9. doi: 10.1016/j.fertnstert.2016.10.035. Epub 2016 Nov 23.
4
MED12 exon 2 mutations in histopathological uterine leiomyoma variants.MED12 外显子 2 突变与组织病理学子宫平滑肌瘤变异。
Eur J Hum Genet. 2013 Nov;21(11):1300-3. doi: 10.1038/ejhg.2013.33. Epub 2013 Feb 27.
5
Mutations in Exon 1 highlight the role of MED12 in uterine leiomyomas.外显子1中的突变突出了MED12在子宫平滑肌瘤中的作用。
Hum Mutat. 2014 Sep;35(9):1136-41. doi: 10.1002/humu.22612. Epub 2014 Jul 21.
6
MED12 exon 2 mutations in uterine and extrauterine smooth muscle tumors.MED12 外显子 2 突变在子宫和子宫外平滑肌肿瘤中的作用。
Hum Pathol. 2014 Jan;45(1):65-70. doi: 10.1016/j.humpath.2013.08.005. Epub 2013 Nov 4.
7
MED12 and HMGA2 mutations: two independent genetic events in uterine leiomyoma and leiomyosarcoma.MED12和HMGA2突变:子宫平滑肌瘤和平滑肌肉瘤中的两个独立遗传事件。
Mod Pathol. 2014 Aug;27(8):1144-53. doi: 10.1038/modpathol.2013.243. Epub 2014 Jan 3.
8
MED12, the mediator complex subunit 12 gene, is mutated at high frequency in uterine leiomyomas.MED12 基因是中介复合物亚基 12 基因,在子宫平滑肌瘤中高频突变。
Science. 2011 Oct 14;334(6053):252-5. doi: 10.1126/science.1208930. Epub 2011 Aug 25.
9
Exomic landscape of MED12 mutation-negative and -positive uterine leiomyomas.MED12 突变阴性和阳性子宫平滑肌瘤的外显子组图谱。
Int J Cancer. 2014 Feb 15;134(4):1008-12. doi: 10.1002/ijc.28410. Epub 2013 Aug 29.
10
Somatic MED12 mutations in prostate cancer and uterine leiomyomas promote tumorigenesis through distinct mechanisms.前列腺癌和子宫平滑肌瘤中的体细胞MED12突变通过不同机制促进肿瘤发生。
Prostate. 2016 Jan;76(1):22-31. doi: 10.1002/pros.23092. Epub 2015 Sep 18.

本文引用的文献

1
RISING STARS: Role of MED12 mutation in the pathogenesis of uterine fibroids.新星崛起:MED12 突变在子宫肌瘤发病机制中的作用。
J Mol Endocrinol. 2023 Sep 29;71(4). doi: 10.1530/JME-23-0039. Print 2023 Nov 1.
2
Engineered MED12 mutations drive leiomyoma-like transcriptional and metabolic programs by altering the 3D genome compartmentalization.工程化 MED12 突变通过改变 3D 基因组区室化来驱动平滑肌瘤样转录和代谢程序。
Nat Commun. 2023 Jul 10;14(1):4057. doi: 10.1038/s41467-023-39684-y.
3
A View on Uterine Leiomyoma Genesis through the Prism of Genetic, Epigenetic and Cellular Heterogeneity.
从遗传、表观遗传和细胞异质性的角度看子宫肌瘤的发生。
Int J Mol Sci. 2023 Mar 17;24(6):5752. doi: 10.3390/ijms24065752.
4
Inherited mutations affecting the SRCAP complex are central in moderate-penetrance predisposition to uterine leiomyomas.影响 SRCAP 复合物的遗传突变是中等外显率子宫平滑肌瘤易感性的核心因素。
Am J Hum Genet. 2023 Mar 2;110(3):460-474. doi: 10.1016/j.ajhg.2023.01.009. Epub 2023 Feb 10.
5
Global, regional, and national burden of uterine fibroids in the last 30 years: Estimates from the 1990 to 2019 Global Burden of Disease Study.过去30年全球、区域和国家子宫肌瘤负担:1990年至2019年全球疾病负担研究的估计数。
Front Med (Lausanne). 2022 Nov 7;9:1003605. doi: 10.3389/fmed.2022.1003605. eCollection 2022.
6
A novel uterine leiomyoma subtype exhibits NRF2 activation and mutations in genes associated with neddylation of the Cullin 3-RING E3 ligase.一种新型子宫平滑肌瘤亚型表现出NRF2激活以及与Cullin 3-RING E3连接酶的Neddylation相关基因的突变。
Oncogenesis. 2022 Sep 7;11(1):52. doi: 10.1038/s41389-022-00425-3.
7
Molecular subclass of uterine fibroids predicts tumor shrinkage in response to ulipristal acetate.子宫纤维瘤的分子亚型可预测对乌利司他醋酸酯的肿瘤缩小反应。
Hum Mol Genet. 2023 Mar 20;32(7):1063-1071. doi: 10.1093/hmg/ddac217.
8
Uterine Fibroids: Hiding in Plain Sight.子宫肌瘤:隐匿于无形。
Physiology (Bethesda). 2022 Jan 1;37(1):16-27. doi: 10.1152/physiol.00013.2021.
9
Molecular and Cellular Insights into the Development of Uterine Fibroids.子宫纤维瘤发病机制的分子和细胞研究进展
Int J Mol Sci. 2021 Aug 6;22(16):8483. doi: 10.3390/ijms22168483.
10
The emerging role of mediator complex subunit 12 in tumorigenesis and response to chemotherapeutics.中介体复合物亚基 12 在肿瘤发生和对化疗药物的反应中的新作用。
Cancer. 2020 Mar 1;126(5):939-948. doi: 10.1002/cncr.32672. Epub 2019 Dec 23.